There was no discernible difference in the GPBAR1 expression between the mouse model of the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced motor impairments and cognitive impairment and the control group [146]. Here, GPBAR1 is linked to Cognitive impairment.